Literature DB >> 4140266

Natural history of phenylketonuria and influence of early treatment.

I Smith, O H Wolff.   

Abstract

This study describes the intellectual development of twenty-eight sibling pairs with phenylketonuria in which the index case presented because of retarded development. In twelve pairs (group I) the "second" sibling was born subsequently, and in sixteen (group II) there was a second sibling already in the family at the time of diagnosis of the index case. The intellectual outcome of the second siblings of group II suggests that approximately 1 in 6 or 7 patients with untreated classical phenylketonuria achieves an I.Q. above 70, although with evidence of intellectual impairment. The highly significant difference in intellectual outcome between the early treated second siblings of group I and the late or untreated second siblings of group II demonstrates the beneficial effect of early treatment on the intelligence of affected children.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4140266     DOI: 10.1016/s0140-6736(74)91873-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.

Authors:  Jennifer E Embury; Catherine E Charron; Anatoly Martynyuk; Andreas G Zori; Bin Liu; Syed F Ali; Neil E Rowland; Philip J Laipis
Journal:  Brain Res       Date:  2006-11-15       Impact factor: 3.252

2.  Connecting mutant phenylalanine hydroxylase with phenylketonuria.

Authors:  Shaomin Yan; Guang Wu
Journal:  J Clin Monit Comput       Date:  2008-09-05       Impact factor: 2.502

3.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

4.  Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.

Authors:  Filippo Manti; Francesca Nardecchia; Sabrina Paci; Flavia Chiarotti; Claudia Carducci; Carla Carducci; Silvia Dalmazzone; Graziella Cefalo; Elisabetta Salvatici; Giuseppe Banderali; Vincenzo Leuzzi
Journal:  J Inherit Metab Dis       Date:  2017-08-23       Impact factor: 4.982

Review 5.  Severe mental handicap: pathogenesis, treatment, and prevention.

Authors:  M D Crawfurd
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

6.  Prevention--everybody's responsibility.

Authors:  W W Holland; A Wainwright
Journal:  Soz Praventivmed       Date:  1978-12

7.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

8.  Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.

Authors:  P H Verkerk; F J van Spronsen; G P Smit; R C Sengers
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

9.  Behavioural deviance in children with early treated phenylketonuria.

Authors:  J E Stevenson; J Hawcroft; M Lobascher; I Smith; O H Wolff; P J Graham
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

Review 10.  Diseases of phenylalanine metabolism.

Authors:  C E Parker
Journal:  West J Med       Date:  1979-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.